ADM and Sepsis: In an ICU setting it may be comparable to other emerging biomarkers, including pro-adrenomedullin [19] and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) [20], and a combination of these biomarkers may be superior for the diagnosis of sepsis compared to either used alone.